Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma [PDF]
Michiko Yamashita +9 more
openalex +1 more source
HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions
Risk mitigation strategies, including donors/recipients screening, DNAemia monitoring in recipients at risk, CNI‐to‐mTOR inhibitors switch, antivirals, and rituximab for KICS, may mitigate the impact of HHV‐8/KSHV infection in SOT. This review provides an update on KICS, identifies research gaps, and summarizes advances in screening and management ...
Alessandra Mularoni +9 more
wiley +1 more source
TOX expression in cutaneous B-cell lymphomas [PDF]
Anne M.R. Schrader +2 more
openalex +1 more source
Extracorporeal photopheresis—New insights into an old procedure
Abstract Background Extracorporeal photopheresis (ECP) is a safe immunomodulatory strategy that induces cell‐type selective apoptosis through photodynamic processes. Despite decades of use, the mechanisms underlying ECP remain largely unexplored, particularly in studies examining specific immune cell subsets in ex vivo setups.
Sabine Seiffert +10 more
wiley +1 more source
Prevalence, clinical features, and survival outcome trends of 627 patients with primary cutaneous lymphoma over 29 years: a retrospective review from single tertiary center in Korea. [PDF]
Moon IJ +7 more
europepmc +1 more source
Classification and clinical features in 88 cases of equine cutaneous lymphoma
Craig A. Miller +5 more
semanticscholar +1 more source
Evaluating VEGFR2 as a Target for Anti‐Tumour Therapy in Canine Melanoma
ABSTRACT Vascular endothelial growth factor receptor 2 (VEGFR2) is a key target for anti‐angiogenic oncotherapy, as inhibiting this receptor on tumour vasculature slows tumour development and enhances drug‐ and immune infiltration, improving therapy outcome.
Esther Hindriks +5 more
wiley +1 more source
Corrigendum: Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines. [PDF]
Papadavid E +7 more
europepmc +1 more source

